Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents
- PMID: 16517404
- DOI: 10.1016/j.cmet.2006.02.004
Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents
Abstract
The endogenous lipid signaling agent oleoylethanolamide (OEA) has recently been described as a peripherally acting agent that reduces food intake and body weight gain in rat feeding models. This paper presents evidence that OEA is an endogenous ligand of the orphan receptor GPR119, a G protein-coupled receptor (GPCR) expressed predominantly in the human and rodent pancreas and gastrointestinal tract and also in rodent brain, suggesting that the reported effects of OEA on food intake may be mediated, at least in part, via the GPR119 receptor. Furthermore, we have used the recombinant receptor to discover novel selective small-molecule GPR119 agonists, typified by PSN632408, which suppress food intake in rats and reduce body weight gain and white adipose tissue deposition upon subchronic oral administration to high-fat-fed rats. GPR119 therefore represents a novel and attractive potential target for the therapy of obesity and related metabolic disorders.
Similar articles
-
GPR119 is required for physiological regulation of glucagon-like peptide-1 secretion but not for metabolic homeostasis.J Endocrinol. 2009 May;201(2):219-30. doi: 10.1677/JOE-08-0453. Epub 2009 Mar 12. J Endocrinol. 2009. PMID: 19282326
-
Oleoylethanolamide, an endogenous PPAR-alpha agonist, lowers body weight and hyperlipidemia in obese rats.Neuropharmacology. 2005 Jun;48(8):1147-53. doi: 10.1016/j.neuropharm.2005.02.013. Epub 2005 Apr 21. Neuropharmacology. 2005. PMID: 15910890
-
Analysis of gene expression pattern reveals potential targets of dietary oleoylethanolamide in reducing body fat gain in C3H mice.J Nutr Biochem. 2010 Oct;21(10):922-8. doi: 10.1016/j.jnutbio.2009.07.006. Epub 2009 Dec 1. J Nutr Biochem. 2010. PMID: 19954948
-
GPR119 as a fat sensor.Trends Pharmacol Sci. 2012 Jul;33(7):374-81. doi: 10.1016/j.tips.2012.03.014. Epub 2012 May 2. Trends Pharmacol Sci. 2012. PMID: 22560300 Review.
-
Oleoylethanolamide: A novel pharmaceutical agent in the management of obesity-an updated review.J Cell Physiol. 2019 Jun;234(6):7893-7902. doi: 10.1002/jcp.27913. Epub 2018 Dec 7. J Cell Physiol. 2019. PMID: 30537148 Review.
Cited by
-
Endogenous molecules stimulating N-acylethanolamine-hydrolyzing acid amidase (NAAA).ACS Chem Neurosci. 2012 May 16;3(5):379-85. doi: 10.1021/cn300007s. Epub 2012 Jan 27. ACS Chem Neurosci. 2012. PMID: 22860206 Free PMC article.
-
Free fatty acid receptors: emerging targets for treatment of diabetes and its complications.Ther Adv Endocrinol Metab. 2010 Aug;1(4):165-75. doi: 10.1177/2042018810381066. Ther Adv Endocrinol Metab. 2010. PMID: 23148161 Free PMC article.
-
Peripheral neural targets in obesity.Br J Pharmacol. 2012 Jul;166(5):1537-58. doi: 10.1111/j.1476-5381.2012.01951.x. Br J Pharmacol. 2012. PMID: 22432806 Free PMC article. Review.
-
Glial Modulation by N-acylethanolamides in Brain Injury and Neurodegeneration.Front Aging Neurosci. 2016 Apr 26;8:81. doi: 10.3389/fnagi.2016.00081. eCollection 2016. Front Aging Neurosci. 2016. PMID: 27199733 Free PMC article. Review.
-
Decreased Hyocholic Acid and Lysophosphatidylcholine Induce Elevated Blood Glucose in a Transgenic Porcine Model of Metabolic Disease.Metabolites. 2022 Nov 23;12(12):1164. doi: 10.3390/metabo12121164. Metabolites. 2022. PMID: 36557202 Free PMC article.
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases